| ID | 504 |
|---|
| No | 504 |
|---|
| Brand Name | HALAVEN SOLUTION FOR INJECTION |
|---|
| Ingredients | EACH VIAL (2 ML) CONTAINS: ERIBULIN MESYLATE 1 MG EQ.TO ERIBULIN 0.88 MG. |
|---|
| Dosage Form | SOLUTION FOR INJECTION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL X 2ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER WHO HAVE PROGRESSED AFTER AT LEAST TWO CHEMOTHERAPEUTIC REGIMENS FOR ADVANCED DISEASE. PRIOR THERAPY SHOULD HAVE INCLUDED AN ANTHRACYCLINE AND A TAXANE UNLESS PATIENTS WERE NOT SUITAB |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | 5 ML CLEAR GLASS VIAL CONTAINING A CLEAR, COLOURLESS SOLUTION ESPECIALLY FREE FROM VISIBLE PARTICLES OF FOREIGN MATTER |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | BSP PHARMACEUTICALS S.P.A |
|---|
| Country | ITALY |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 09 I 3897/13 |
|---|
| FDD Registration Date | 08/01/2024 |
|---|
| Expiry Date | 07/01/2027 |
|---|
